Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 196 (12) , 835-840
- https://doi.org/10.1016/s0344-0338(00)80084-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Value of Thyroid Transcription Factor-1, E-Cadherin, BG8, WT1, and CD44S Immunostaining in Distinguishing Epithelial Pleural Mesothelioma From Pulmonary and Nonpulmonary AdenocarcinomaThe American Journal of Surgical Pathology, 2000
- Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and BHistopathology, 2000
- Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and merkel cell tumorHuman Pathology, 2000
- Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesotheliomaHuman Pathology, 1999
- TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lungCancer Letters, 1998
- Thyroid Transcription Factor-1 and Cytokeratins 7 and 20 in Pulmonary and Breast CarcinomaActa Cytologica, 1998
- P53 in Breast Carcinomas: Association Between Presence of Mutation and Immunohistochemical Expression Using a Semiquantitative ApproachPathology - Research and Practice, 1998
- Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1Journal of Neuro-Oncology, 1998
- Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.Journal of Clinical Pathology, 1997
- TTF-1 gene expression in human lung tumoursEuropean Journal Of Cancer, 1996